Sang, Y.;                     Tsuji, K.;                     Inoue-Torii, A.;                     Fukushima, K.;                     Kitamura, S.;                     Wada, J.    
        Semaphorin3A-Inhibitor Ameliorates Doxorubicin-Induced Podocyte Injury. Int. J. Mol. Sci. 2020, 21, 4099.
    https://doi.org/10.3390/ijms21114099
    AMA Style
    
                                Sang Y,                                 Tsuji K,                                 Inoue-Torii A,                                 Fukushima K,                                 Kitamura S,                                 Wada J.        
                Semaphorin3A-Inhibitor Ameliorates Doxorubicin-Induced Podocyte Injury. International Journal of Molecular Sciences. 2020; 21(11):4099.
        https://doi.org/10.3390/ijms21114099
    
    Chicago/Turabian Style
    
                                Sang, Yizhen,                                 Kenji Tsuji,                                 Akiko Inoue-Torii,                                 Kazuhiko Fukushima,                                 Shinji Kitamura,                                 and Jun Wada.        
                2020. "Semaphorin3A-Inhibitor Ameliorates Doxorubicin-Induced Podocyte Injury" International Journal of Molecular Sciences 21, no. 11: 4099.
        https://doi.org/10.3390/ijms21114099
    
    APA Style
    
                                Sang, Y.,                                 Tsuji, K.,                                 Inoue-Torii, A.,                                 Fukushima, K.,                                 Kitamura, S.,                                 & Wada, J.        
        
        (2020). Semaphorin3A-Inhibitor Ameliorates Doxorubicin-Induced Podocyte Injury. International Journal of Molecular Sciences, 21(11), 4099.
        https://doi.org/10.3390/ijms21114099